The Airflow Study Part 2

Start date

Jan 21st

Renumeration

$9,925

3 nights + 2 nights + 2 nights, 9 appointments

Help Test a New Treatment for Chronic Obstructive Pulmonary Disease

This clinical study is evaluating a new treatment for Chronic Obstructive Pulmonary Disease, a condition that results in difficulty breathing, wheezing and tiredness. The primary goal is to assess the safety and tolerability of the treatment in healthy adult participants.

Apply Now

Example Schedule

Participation requires completion of three designated stay periods.
The dates for each period are listed below by cohort.

Cohort 3.1

Period 1

Check In

Jan 21st

Check Out

Jan 24th

Period 2

Check In

Feb 05th

Check Out

Feb 07th

Period 3

Check In

Feb 19th

Check Out

Feb 21st

9 appointment

Jan 29th, Feb 12th, 26th, Mar 05th, 19th, Apr 16th, May 14th, Jun 11th, Jul 09th

To Qualify, You Must

Age

Be 18 to 65 years old

Gender

Be a healthy male or female

Physical Condition

NOT have any allergies to food or medications Have NO significant medical conditions

Requirements

Have a BMI between 18 and 32kg/m2

Renumeration

$9,925 *Screening Reimbursement of $100–$250 applies, please see Terms

Help Test a New Treatment for Chronic Obstructive Pulmonary Disease

Spots are limited. Find out if you qualify today!

Apply Now